Who owns the JOURNAL OF CLINICAL ONCOLOGY trademark?

The JOURNAL OF CLINICAL ONCOLOGY trademark is owned by American Society of Clinical Oncology, Inc..

What class is the JOURNAL OF CLINICAL ONCOLOGY trademark registered in?

The JOURNAL OF CLINICAL ONCOLOGY trademark is registered in Class 009 (Electronics, software & scientific instruments).

What is the serial number for JOURNAL OF CLINICAL ONCOLOGY?

The USPTO serial number for JOURNAL OF CLINICAL ONCOLOGY is 87719641.

What is the registration number for JOURNAL OF CLINICAL ONCOLOGY?

JOURNAL OF CLINICAL ONCOLOGY is registered under USPTO registration number 5688705.

JOU

USPTO Trademark Record

REGISTERED

JOURNAL OF CLINICAL ONCOLOGY

SN 87719641·Reg 5688705·Filed Dec 13, 2017

Owner American Society of Clinical Oncology, Inc.

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable multimedia files, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus.

JOURNAL OF CLINICAL ONCOLOGY (Serial No. 87719641), Registration No. 5688705, is a registered US trademark filed on Dec 13, 2017 by American Society of Clinical Oncology, Inc.. This trademark covers Class 009 (Electronics, software & scientific instruments).

Section 8/9 declaration window: March 05, 2029

Mark Intelligence

JOURNAL OF CLINICAL ONCOLOGY (Reg. #5688705) is a registered US trademark that has been protecting its owner, American Society of Clinical Oncology, Inc., since 2017. The mark covers Class 009 (Electronics, software & scientific instruments). Goods and services include Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, s.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 13, 2017

SERIAL

87719641

REG#

5688705

REGISTERED

Mar 05, 2019

Owner

Applicant

American Society of Clinical Oncology, Inc.

Entity

Not Provided

State

Address

2318 Mill Road, Suite 800, Alexandria, VA, 22314

Country

Attorney

NameEmilia F. Cannella

Law firm

Emilia F. Cannella ROPES & GRAY LLP

Docket

ASCO-T-088

Address

PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON, MA 02199-3600, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 13, 2017

Serial Number87719641

Registration No.5688705

Registration DateMar 05, 2019

Status DateOct 31, 2024

Published for OppositionDec 18, 2018

Next RenewalMarch 05, 2029

Mark TypeStandard characters

Attorney DocketASCO-T-088

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 009Electronics, software & scientific instruments

US codes: 021, 023, 026, 036, 038

First use anywhere: Jan 01, 1999

First use in commerce: Jan 01, 1999

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

23 events

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Oct 31, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Oct 31, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 30, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

May 08, 2024

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 05, 2024

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Mar 05, 2019

REGISTERED-PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Feb 19, 2019

ASSIGNED TO EXAMINER

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 18, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Dec 18, 2018

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 28, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Nov 09, 2018

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Nov 09, 2018

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 25, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 24, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 24, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 24, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION E-MAILED

Apr 24, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 24, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Apr 24, 2018

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 10, 2018

ASSIGNED TO EXAMINER

Mar 23, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 27, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 16, 2017

NEW APPLICATION ENTERED

JOURNAL OF CLINICAL ONCOLOGY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by American Society of Clinical Oncology, Inc.

Other Marks in Class 009 — Electronics, software & scientific instruments

Other Marks by Emilia F. Cannella

Resources

Company